Chief Financial Officer at HCW Biologics Exercises Options Worth $83K

Rebecca Byam, Chief Financial Officer at HCW Biologics (NASDAQ:HCWB), reported a large exercise of company stock options on October 23, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Byam, Chief Financial Officer at HCW Biologics, a company in the Health Care sector, just exercised stock options worth 47,249 shares of HCWB stock with an exercise price of $0.14.

HCW Biologics shares are trading down 1.12% at $1.77 at the time of this writing on Tuesday morning. Since the current price is $1.77, this makes Byam's 47,249 shares worth $83,630.

Now trade stocks online commission free with Charles ...

Full story available on

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner